News + Resources
Keep up with the latest
Featured
Epigenetic editors are a gentler form of gene editing
February 24, 2025
The Economist
Epigenetic editors are a gentler form of gene editing
February 24, 2025
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
November 25, 2024
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
November 25, 2024
All Stories
News
Towards an AI-Driven CRISPR Future
February 11, 2025
SynBioBeta
Read Now
Press Release
Towards an AI-Driven CRISPR Future
February 11, 2025
SynBioBeta
Read Now
News
2025 predictions: Which trends are set to shape the biotech industry this year?
January 13, 2025
Labiotech
Read Now
Press Release
2025 predictions: Which trends are set to shape the biotech industry this year?
January 13, 2025
Labiotech
Read Now
Press Release
Scribe Therapeutics Achieves Milestone for In Vivo Program in Collaboration with Sanofi
January 13, 2025
Read Now
Press Release
Scribe Therapeutics Achieves Milestone for In Vivo Program in Collaboration with Sanofi
January 13, 2025
Read Now
Press Release
Scribe Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 9, 2025
Read Now
Press Release
Scribe Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 9, 2025
Read Now
News
From The Lab To The Clinic: Developing And Delivering The Next Generation Of Therapies To Patients In Need
December 6, 2024
Forbes Healthcare Summit
Read Now
Press Release
From The Lab To The Clinic: Developing And Delivering The Next Generation Of Therapies To Patients In Need
December 6, 2024
Forbes Healthcare Summit
Read Now